Managing comorbid cardiovascular disease and sleep apnea with pharmacotherapy

References

• Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012;687–701.
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1235.
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–1014.
   PubMed Web of Science ®Google Scholar
• Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310–318.
   PubMed Web of Science ®Google Scholar
• Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52:686–717.
   PubMed Web of Science ®Google Scholar
• Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014;1311:151–173.
   PubMed Web of Science ®Google Scholar
• Florczak E, Prejbisz A, Szwench-Pietrasz E, et al. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. J Hum Hypertens. 2013;27:678–685.
   PubMed Web of Science ®Google Scholar
• Ludka O, Stepanova R, Vyskocilova M, et al. Sleep apnea prevalence in acute myocardial infarction – the sleep apnea in post-acute myocardial infarction patients (SAPAMI) Study. Int J Cardiol. 2014;176:13–19.
   PubMed Web of Science ®Google Scholar
• Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841–858.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
   PubMed Web of Science ®Google Scholar
• Tykarski A, Narkiewicz K, Gaciong Z, et al. guidelines for the management of hypertension. Recommendations of the polish society of hypertension – short version. Kardiol Pol. 2015;73:676–700.
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses. J Hypertens. 2015;33:1321–1341.
   PubMed Web of Science ®Google Scholar
• Borgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens. 2004;17:1081–1087.
   PubMedGoogle Scholar
• Diogo LN, Pinto P, Barbara C, et al. The association between antihypertensive medication and blood pressure control in patients with obstructive sleep apnea. Adv Exp Med Biol. 2015;860:201–209.
   PubMed Web of Science ®Google Scholar
• Bollig SM. Encouraging CPAP adherence: it is everyone’s job. Respir Care. 2010;55:1230–1239.
   PubMed Web of Science ®Google Scholar
• Schwarz EI, Schlatzer C, Rossi VA, et al. Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials. Chest. 2016 Dec;150(6):1202–1210. doi: 10.1016/j.chest.2016.07.012.
   Google Scholar
• Pelttari LH, Hietanen EK, Salo TT, et al. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens. 1998;11:272–279.
   PubMed Web of Science ®Google Scholar
• Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–646.
   PubMed Web of Science ®Google Scholar
• Hedner J, Ejnell H, Sellgren J, et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl. 1988;6:S529–31.
   PubMedGoogle Scholar
• Carlson JT, Hedner J, Elam M, et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993;103:1763–1768.
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–1904.
   PubMed Web of Science ®Google Scholar
• Leuenberger U, Jacob E, Sweer L, et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol (1985). 1995;79:581–588.
   PubMed Web of Science ®Google Scholar
• Narkiewicz K, van de Borne PJ, Cooley RL, et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772–776.
   PubMed Web of Science ®Google Scholar
• Kirby DA, Pinto JM, Weiss JW, et al. Effects of beta adrenergic receptor blockade on hemodynamic changes associated with obstructive sleep apnea. Physiol Behav. 1995;58:919–923.
   PubMed Web of Science ®Google Scholar
• Planes C, Foucher A, Leroy M, et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep. 1999;22:507–513.
   PubMed Web of Science ®Google Scholar
• Salo TM, Kantola I, Voipio-Pulkki LM, et al. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients – assessment by spectral analysis of heart rate and blood pressure variability. Eur J Clin Pharmacol. 1999;55:191–198.
   PubMed Web of Science ®Google Scholar
• Kraiczi H, Hedner J, Peker Y, et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161:1423–1428.
   PubMed Web of Science ®Google Scholar
• Mayer J, Weichler U, Herres-Mayer B, et al. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol. 1990;16:952–961.
   PubMed Web of Science ®Google Scholar
• Tilkian AG, Guilleminault C, Schroeder JS, et al. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med. 1977;63:348–358.
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Connolly S, Winkle R, et al. Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet. 1984;1:126–131.
   PubMed Web of Science ®Google Scholar
• Wolf J, Drozdowski J, Czechowicz K, et al. Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome. Int J Cardiol. 2016;202:67–72.
   PubMed Web of Science ®Google Scholar
• Friedman O, Bradley TD, Chan CT, et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010;56:1077–1082.
   PubMed Web of Science ®Google Scholar
• Yadollahi A, Gabriel JM, White LH, et al. A randomized, double crossover study to investigate the influence of saline infusion on sleep apnea severity in men. Sleep. 2014;37:1699–1705.
   PubMed Web of Science ®Google Scholar
• Kasai T, Bradley TD, Friedman O, et al. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension. J Hypertens. 2014;32:673–680.
   PubMed Web of Science ®Google Scholar
• Redolfi S, Arnulf I, Pottier M, et al. Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med. 2011;184:1062–1066.
   PubMed Web of Science ®Google Scholar
• Redolfi S, Arnulf I, Pottier M, et al. Effects of venous compression of the legs on overnight rostral fluid shift and obstructive sleep apnea. Respir Physiol Neurobiol. 2011;175:390–393.
   PubMed Web of Science ®Google Scholar
• Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811–817.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Nishizaka MK, Zaman MA, et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125:112–117.
   PubMed Web of Science ®Google Scholar
• Prejbisz A, Florczak E, Klisiewicz A, et al. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension. Endokrynol Pol. 2013;64:363–367.
   PubMed Web of Science ®Google Scholar
• Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med. 2010;6:363–368.
   PubMed Web of Science ®Google Scholar
• Meston N, Davies RJ, Mullins R, et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med. 2003;254:447–454.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Jiang XT, Zhang XB, et al. Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea? Sleep Breath. 2016;20:921–928.
   PubMed Web of Science ®Google Scholar
• Lloberes P, Sampol G, Espinel E, et al. A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea. J Hypertens. 2014;32:1650–7; discussion 7.
   PubMed Web of Science ®Google Scholar
• de Souza F, Muxfeldt ES, Margallo V, et al. Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial. J Hypertens. 2017;35:837–844.
   PubMed Web of Science ®Google Scholar
• Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24:532–537.
   PubMed Web of Science ®Google Scholar
• Krasinska B, Miazga A, Cofta S, et al. Effect of eplerenone on the severity of obstructive sleep apnea and arterial stiffness in patients with resistant arterial hypertension. Pol Arch Med Wewn. 2016;126:330–339.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang H, Cai M, et al. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clin Exp Hypertens. 2016;38:464–468.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for high blood pressure research. Circulation. 2008;117:e510–26.
   PubMed Web of Science ®Google Scholar
• Joyeux-Faure M, Jullian-Desayes I, Pepin JL, et al. Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: a randomized controlled pilot study. Respirology. 2016;21:546–552.
   PubMed Web of Science ®Google Scholar
• Zou D, Grote L, Eder DN, et al. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients. Sleep Med. 2010;11:325–328.
   PubMed Web of Science ®Google Scholar
• Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, et al. Association between refractory hypertension and obstructive sleep apnea. J Hypertens. 2009;27:1439–1445.
   PubMed Web of Science ®Google Scholar
• Shantha GP, Pancholy SB. Effect of renal sympathetic denervation on apnea–hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2015;19:29–34.
   PubMed Web of Science ®Google Scholar
• Narkiewicz K, Ratcliffe LEK, Hart EC, et al. Unilateral carotid body resection in resistant hypertension: a safety and feasibility trial. JACC: Basic to Translational Science. 2016;1:313–324.
   PubMedGoogle Scholar
• Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax. 2000;55:736–740.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Pino JM, Alonso A, et al. White coat hypertension in patients with obstructive sleep apnea–hypopnea syndrome. Chest. 2004;125:817–822.
   PubMed Web of Science ®Google Scholar
• Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005;23:521–527.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–1783.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Kasiakogias A, Thomopoulos C, et al. Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy. J Hypertens. 2010;28:875–882.
   PubMed Web of Science ®Google Scholar
• Kasiakogias A, Tsioufis C, Thomopoulos C, et al. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens. 2015;33:393–400.
   PubMed Web of Science ®Google Scholar
• Serinel Y, Yee BJ, Grunstein RR, et al. Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial. Thorax. 2017;72:550–558.
   PubMed Web of Science ®Google Scholar
• Baguet JP, Levy P, Barone-Rochette G, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens. 2008;26:885–892.
   PubMed Web of Science ®Google Scholar
• Seif F, Patel SR, Walia HK, et al. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens. 2014;32:267–275.
   PubMed Web of Science ®Google Scholar
• Pepin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;182:954–960.
   PubMed Web of Science ®Google Scholar
• Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598–1605.
   PubMed Web of Science ®Google Scholar
• Roca GQ, Redline S, Claggett B, et al. Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort: the atherosclerosis risk in communities-sleep heart health study. Circulation. 2015;132:1329–1337.
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–360.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–1105.
   PubMed Web of Science ®Google Scholar
• Lyons OD, Floras JS, Logan AG, et al. Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial. Eur J Heart Fail. 2017;19:579–587.
   PubMed Web of Science ®Google Scholar
• Javaheri S, Brown LK, Randerath W, et al. SERVE-HF: more questions than answers. Chest. 2016;149:900–904.
   PubMed Web of Science ®Google Scholar
• Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest. 2007;132:440–446.
   PubMed Web of Science ®Google Scholar
• Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol. 2004;44:68–71.
   PubMed Web of Science ®Google Scholar
• Gabor JY, Newman DA, Barnard-Roberts V, et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J. 2005;26:95–100.
   PubMed Web of Science ®Google Scholar
• Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996;335:562–567.
   PubMed Web of Science ®Google Scholar
• Ueno LM, Drager LF, Rodrigues AC, et al. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep. 2009;32:637–647.
   PubMed Web of Science ®Google Scholar
• Joho S, Oda Y, Hirai T, et al. Impact of sleeping position on central sleep apnea/Cheyne-Stokes respiration in patients with heart failure. Sleep Med. 2010;11:143–148.
   PubMed Web of Science ®Google Scholar
• Wolf J, Swierblewska E, Jasiel-Wojculewicz H, et al. Theophylline therapy for cheyne-stokes respiration during sleep in a 41-year-old man with refractory arterial hypertension. Chest. 2014;146:E8–E13.
   PubMed Web of Science ®Google Scholar
• Lamba J, Simpson CS, Redfearn DP, et al. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace. 2011;13:1174–1179.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233–1241.
   PubMed Web of Science ®Google Scholar
• Usui K, Bradley TD, Spaak J, et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol. 2005;45:2008–2011.
   PubMed Web of Science ®Google Scholar
• Szymanski FM, Platek AE, Karpinski G, et al. Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population. Kardiol Pol. 2014;72:716–724.
   PubMed Web of Science ®Google Scholar
• Wolf J, Derezinski T, Szyndler A, et al. Prevalence and characteristics of OSAFED syndrome in atrial fibrillation primary care patients. Kardiol Pol. 2017;75:432–438.
   PubMed Web of Science ®Google Scholar
• Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–367.
   PubMed Web of Science ®Google Scholar
• Porthan KM, Melin JH, Kupila JT, et al. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest. 2004;125:879–885.
   PubMed Web of Science ®Google Scholar
• Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med. 2006;173:910–916.
   PubMed Web of Science ®Google Scholar
• Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–2594.
   PubMed Web of Science ®Google Scholar
• Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62:300–305.
   PubMed Web of Science ®Google Scholar
• Naruse Y, Tada H, Satoh M, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10:331–337.
   PubMed Web of Science ®Google Scholar
• Jongnarangsin K, Chugh A, Good E, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:668–672.
   PubMed Web of Science ®Google Scholar
• Patel D, Mohanty P, Di Biase L, et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol. 2010;3:445–451.
   PubMed Web of Science ®Google Scholar
• Li L, Wang ZW, Li J, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16:1309–1314.
   PubMedGoogle Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;2016(37):2893–2962.
   Web of Science ®Google Scholar
• Yaranov DM, Smyrlis A, Usatii N, et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015;115:461–465.
   PubMed Web of Science ®Google Scholar
• Szymanski FM, Lip GY, Filipiak KJ, et al. Stroke risk factors beyond the CHA(2)DS(2)-VASc score: can we improve our identification of ‘high stroke risk’ patients with atrial fibrillation? Am J Cardiol. 2015;116:1781–1788.
   PubMed Web of Science ®Google Scholar
• Yazdan-Ashoori P, Baranchuk A. Obstructive sleep apnea may increase the risk of stroke in AF patients: refining the CHADS2 score. Int J Cardiol. 2011 Jan 21;146(2):131–133. doi: 10.1016/j.ijcard.2010.10.104.
   Web of Science ®Google Scholar
• Szymanski FM, Lip GY, Filipiak KJ, et al. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. Int J Cardiol. 2016;204:200–205.
   PubMed Web of Science ®Google Scholar
• Hedner J, Grote L, Zou D. Pharmacological treatment of sleep apnea: current situation and future strategies. Sleep Med Rev. 2008;12:33–47.
   PubMed Web of Science ®Google Scholar
• Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs. 2008;68:1803–1839.
   PubMed Web of Science ®Google Scholar
• Marzullo P, Menegatti M, Guzzaloni G, et al. Cocaine abuse and sleep apnea in severe obesity. J Addict Med. 2013;7:294–295.
   PubMed Web of Science ®Google Scholar
• Shah SA, Chu BW, Lacey CS, et al. Impact of acute energy drink consumption on blood pressure parameters: a meta-analysis. Ann Pharmacother. 2016;50:808–815.
   PubMed Web of Science ®Google Scholar
• Goldstein RA, DesLauriers C, Burda AM. Cocaine: history, social implications, and toxicity – a review. Dis Mon. 2009;55:6–38.
   PubMed Web of Science ®Google Scholar
• Jullian-Desayes I, Revol B, Chareyre E, et al. Impact of concomitant medications on obstructive sleep apnoea. Br J Clin Pharmacol. 2017;83:688–708.
   PubMed Web of Science ®Google Scholar
• Chai-Coetzer CL, Luo YM, Antic NA, et al. Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. Sleep. 2013;36:1929–1937.
   PubMed Web of Science ®Google Scholar
• Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr. 2009;121:398–404.
   PubMed Web of Science ®Google Scholar
• Ye L, Antonelli MT, Willis DG, et al. Couples’ experiences with continuous positive airway pressure treatment: a dyadic perspective. Sleep Health. 2017;3:362–367.
   PubMed Web of Science ®Google Scholar
• Brostrom A, Stromberg A, Martensson J, et al. Association of type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res. 2007;16:439–447.
   PubMed Web of Science ®Google Scholar
• Poulet C, Veale D, Arnol N, et al. Psychological variables as predictors of adherence to treatment by continuous positive airway pressure. Sleep Med. 2009;10:993–999.
   PubMed Web of Science ®Google Scholar
• Billings ME, Auckley D, Benca R, et al. Race and residential socioeconomics as predictors of CPAP adherence. Sleep. 2011;34:1653–1658.
   PubMed Web of Science ®Google Scholar
• Sparrow D, Aloia M, Demolles DA, et al. A telemedicine intervention to improve adherence to continuous positive airway pressure: a randomised controlled trial. Thorax. 2010;65:1061–1066.
   PubMed Web of Science ®Google Scholar
• Jacobsen AR, Eriksen F, Hansen RW, et al. Determinants for adherence to continuous positive airway pressure therapy in obstructive sleep apnea. PLoS ONE. 2017;12:e0189614.
   PubMed Web of Science ®Google Scholar
• Park P, Kim J, Song YJ, et al. Influencing factors on CPAP adherence and anatomic characteristics of upper airway in OSA subjects. Medicine (Baltimore). 2017;96:e8818.
   PubMed Web of Science ®Google Scholar
• Djavadkhani Y, Marshall NS, D’Rozario AL, et al. Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial. Thorax. 2015;70:265–269.
   PubMed Web of Science ®Google Scholar